Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Tropical Medicine and Hygiene|January 29, 2014
Occurrence and correlates of symptom persistence following acute dengue fever in PeruEric S Halsey, Maya Williams, V Alberto Laguna-Torres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2011
Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008Sabra L Klein, Morgan A Marks, Wei Li, et al.
The Journal of Infectious Diseases|December 18, 2012
A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United StatesPatti E Gravitt, Anne F Rositch, Michelle I Silver, et al.
AIDS (London, England)|November 22, 2012
Markers of microbial translocation and risk of AIDS-related lymphomaMorgan A Marks, Charles S Rabkin, Eric A Engels, et al.
Plos Neglected Tropical Diseases|May 8, 2012
Correlation of serotype-specific dengue virus infection with clinical manifestationsEric S Halsey, Morgan A Marks, Eduardo Gotuzzo, et al.
Cancer|August 8, 2022
Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factorsSarah S Jackson, Morgan A Marks, Hormuzd A Katki, et al.
Open Forum Infectious Diseases|December 18, 2024
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19-related Hospitalizations and Medical Encounters Among Adults in the United StatesHagit Kopel, Andre B Araujo, Alina Bogdanov, et al.
BMC Infectious Diseases|April 19, 2015
Prevalence and correlates of HPV among women attending family-planning clinics in ThailandMorgan A Marks, Swati Gupta, Kai-Li Liaw, et al.
Emerging Infectious Diseases|April 16, 2026
Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016-2021Eliana Nogueira Castro de Barros, Manuela de Almeida Roediger, Maïna L'Azou Jackson, et al.
Vaccine|July 19, 2024
Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United StatesBrenna Kirk, Christopher Bush, Astra Toyip, et al.
Pageof 5